| FANAX | MLOIX | FANAX / MLOIX | |
| Total Expense Ratio | 0.98 | 0.90 | 109% |
| Annual Report Gross Expense Ratio | 0.98 | 1.37 | 72% |
| Fund Existence | 29 years | 12 years | - |
| Gain YTD | 12.625 | 19.206 | 66% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 895M | 122M | 734% |
| Annual Yield % from dividends | 0.88 | 4.37 | 20% |
| Returns for 1 year | 4.79 | 14.03 | 34% |
| Returns for 3 years | 12.77 | 41.94 | 30% |
| Returns for 5 years | 219.22 | 162.32 | 135% |
| Returns for 10 years | 81.58 | 118.82 | 69% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FZALX | 30.14 | N/A | N/A |
| Fidelity Advisor Mega Cap Stock Z | |||
| RYAZX | 208.10 | N/A | N/A |
| Rydex S&P SmallCap 600 Pure Value H | |||
| VESGX | 47.30 | N/A | N/A |
| Vanguard Global ESG Select Stk Admiral | |||
| IVGIX | 19.02 | -0.02 | -0.11% |
| VY® Invesco Growth and Income I | |||
| BRWBX | 26.63 | -0.30 | -1.11% |
| MFS Blended Research Growth Eq B | |||